382
Participants
Start Date
September 27, 2017
Primary Completion Date
June 8, 2018
Study Completion Date
June 8, 2018
FFRangio
"FFRangio is a non-invasive image-based software device that provides physicians with a quantitative analysis of functional significance of the coronary lesion, similar to invasive FFR (Fractional Flow Reserve), and a qualitative three-dimensional model of the demonstrated coronary arteries, during routine PCI procedure. The CathWorks FFRangio software device is able to perform all required processing and calculations, based only on angiography images and hemodynamics information that are acquired during the coronary catheterization procedure.~The CathWorks FFRangioTM technology does not require any additional use of invasive devices, or any additional vasodilation treatment, as required by other known FFR techniques."
Rigs Hospital CPH, Copenhagen
OLV Ziekenhuis, Aalst
Columbia University Medical Center/NewYork Presbyterian Hospital, New York
St. Francis Hospital, Roslyn
HaSharon Hospital, Petah Tikva
Rabin Medical Center, Petah Tikva
Stanford University, Stanford
Shaare Zedek Medical Center, Jerusalem
University of Pennsylvania, Philadelphia
Lead Sponsor
CRF
UNKNOWN
CathWorks Ltd.
INDUSTRY